| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1996;93:697-703.)
© 1996 American Heart Association, Inc.
Articles |
Secular Trends in Long-term Sustained Hypertension, Long-term Treatment, and Cardiovascular Mortality
The Framingham Heart Study 1950 to 1990
From the Framingham Heart Study, Framingham, Mass (P.A.S., R.B.D., A.J.B., W.B.K.); the Statistics and Consulting Unit, Department of Mathematics, Boston (Mass) University (P.A.S., R.B.D., A.J.B.); and Section of Preventive Medicine, Department of Medicine, Boston University School of Medicine (W.B.K.).
Background Cardiovascular morbidity and mortality result from the chronic processes involved in hypertension. However, long-term sustained (LTS) hypertension has received little attention.
Methods and Results Trends in the prevalence of LTS
hypertension and its treatment were assessed in 1950, 1960, and 1970
among three cohorts of men and women in the Framingham Heart Study
(Mantel-Haenszel test). Cardiovascular disease (CVD)
incidence and mortality were compared between patients with LTS
hypertension with and without long-term treatment by use of the
2 test. Cox proportional hazards regression
analysis was used to estimate 10-year risk of death as a
function of risk factor levels and treatment. Prevalence of LTS
hypertension rose from 138 to 208 per 1000 between the 1950 and 1970
male cohorts (P<.01), while prevalence fell from 253 to 198
per 1000 between the female cohorts (P<.02). Long-term
treatment increased 51% between the male cohorts and 45% between the
female cohorts (both P<.001). While CVD incidence was
similar (26% versus 25%), all-cause mortality was significantly
lower among men with long-term treatment (31% versus 43%;
P<.05), and CVD mortality was less than half (13% versus
28%; P<.01). Among treated women, all-cause mortality
was 21% (versus 34%; P<.01), and CVD mortality was 9%
(versus 19%; P<.01). Ten-year risk of CVD death for
patients with LTS hypertension with long-term treatment compared
with those without was 0.40 (95% CI, 0.27 to 0.60).
Conclusions This investigation of LTS hypertension, its treatment, and its sequelae in a free-living general population confirms the reduction in CVD mortality demonstrated in more short-term clinical trials of hypertension therapy in select patient groups.
Key Words: trials • hypertension • risk factors • mortality • cardiovascular diseases
This article has been cited by other articles:
 |
|
 |
|
  W. Fang, X. Yang, J. M. Bargman, and D. G. Oreopoulos ASSOCIATION BETWEEN PULSE PRESSURE AND MORTALITY IN PATIENTS UNDERGOING PERITONEAL DIALYSIS Perit. Dial. Int., March 1, 2009; 29(2): 163 - 170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Godwin, A. Pike, A. Kirby, C. Jewer, and L. Murphy Prehypertension and hypertension in a primary care practice Can Fam Physician, October 1, 2008; 54(10): 1418 - 1423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ingelsson, P. Gona, M. G. Larson, D. M. Lloyd-Jones, W. B. Kannel, R. S. Vasan, and D. Levy Altered Blood Pressure Progression in the Community and Its Relation to Clinical Events Arch Intern Med, July 14, 2008; 168(13): 1450 - 1457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Jindal, C. T. Chan, C. Deziel, D. Hirsch, S. D. Soroka, M. Tonelli, and B. F. Culleton CHAPTER 2: Management of Blood Pressure in Hemodialysis Patients J. Am. Soc. Nephrol., March 1, 2006; 17(3_suppl_1): S8 - S10. [Full Text] [PDF]
|
|
|
|
|
|
C. A. Stidley, W. C. Hunt, F. Tentori, D. Schmidt, M. Rohrscheib, S. Paine, E. J. Bedrick, K. B. Meyer, H. K. Johnson, P. G. Zager, et al. Changing Relationship of Blood Pressure with Mortality over Time among Hemodialysis Patients J. Am. Soc. Nephrol., February 1, 2006; 17(2): 513 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Bolduc, V. L. Oliva, E. Therasse, M.-F. Giroux, L. Bouchard, P. Perreault, A. Cliche, and G. Soulez Diagnosis and Treatment of Renovascular Hypertension: A Cost-Benefit Analysis Am. J. Roentgenol., March 1, 2005; 184(3): 931 - 937. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Samson Hypertension and the Vascular Patient Vascular and Endovascular Surgery, March 1, 2004; 38(2): 103 - 119. [Abstract] [PDF]
|
|
|
|
 |
|
 P. S. Klassen, E. G. Lowrie, D. N. Reddan, E. R. DeLong, J. A. Coladonato, L. A. Szczech, J. M. Lazarus, and W. F. Owen Jr Association Between Pulse Pressure and Mortality in Patients Undergoing Maintenance Hemodialysis JAMA, March 27, 2002; 287(12): 1548 - 1555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Vasan, A. Beiser, S. Seshadri, M. G. Larson, W. B. Kannel, R. B. D'Agostino, and D. Levy Residual Lifetime Risk for Developing Hypertension in Middle-aged Women and Men: The Framingham Heart Study JAMA, February 27, 2002; 287(8): 1003 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Seshadri, P. A. Wolf, A. Beiser, R. S. Vasan, P. W. F. Wilson, C. S. Kase, M. Kelly-Hayes, W. B. Kannel, and R. B. D'Agostino Elevated Midlife Blood Pressure Increases Stroke Risk in Elderly Persons: The Framingham Study Arch Intern Med, October 22, 2001; 161(19): 2343 - 2350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Goldman, K. A. Phillips, P. Coxson, P. A. Goldman, L. Williams, M. G. M. Hunink, and M. C. Weinstein The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1012 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. W. Cohen, S. Madhavan, and M. H. Alderman History of Treatment for Depression: Risk Factor for Myocardial Infarction in Hypertensive Patients Psychosom Med, March 1, 2001; 63(2): 203 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. McAlister, N. R.C. Campbell, K. Zarnke, M. Levine, and I. D. Graham The management of hypertension in Canada: a review of current guidelines, their shortcomings and implications for the future Can. Med. Assoc. J., February 1, 2001; 164(4): 517 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Goldman, P. Coxson, M. G. M. Hunink, P. A. Goldman, A. N. A. Tosteson, M. Mittleman, L. Williams, and M. C. Weinstein The relative influence of secondary versus primary prevention using the National Cholesterol Education Program Adult Treatment Panel II guidelines J. Am. Coll. Cardiol., September 1, 1999; 34(3): 768 - 776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Stauss, A. Godecke, R. Mrowka, J. Schrader, and P. B. Persson Enhanced Blood Pressure Variability in eNOS Knockout Mice Hypertension, June 1, 1999; 33(6): 1359 - 1363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mosterd, R. B. D'Agostino, H. Silbershatz, P. A. Sytkowski, W. B. Kannel, D. E. Grobbee, and D. Levy Trends in the Prevalence of Hypertension, Antihypertensive Therapy, and Left Ventricular Hypertrophy from 1950 to 1989 N. Engl. J. Med., April 22, 1999; 340(16): 1221 - 1227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. DeCarli, B. L. Miller, G. E. Swan, T. Reed, P. A. Wolf, J. Garner, L. Jack, and D. Carmelli Predictors of Brain Morphology for the Men of the NHLBI Twin Study Stroke, March 1, 1999; 30(3): 529 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. K Andersson, T. Almgren, B. Persson, O. Samuelsson, T. Hedner, and L. Wilhelmsen Survival in treated hypertension: follow up study after two decades BMJ, July 18, 1998; 317(7152): 167 - 171. [Abstract] [Full Text]
|
|
|
|
|
|
L. R. Yanek, T. F. Moy, R. S. Blumenthal, J. V. Raqueno, R. M. Yook, M. N. Hill, L. C. Becker, and D. M. Becker Hypertension Among Siblings of Persons With Premature Coronary Heart Disease Hypertension, July 1, 1998; 32(1): 123 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S Cooper, C. N Rotimi, J. S Kaufman, W. F. Muna, and G. A Mensah Hypertension treatment and control in sub-Saharan Africa: the epidemiological basis for policy BMJ, February 14, 1998; 316(7131): 614 - 617. [Full Text]
|
|
|
|
 |
|
 A. V. Chobanian Have Long-term Benefits of Antihypertensive Therapy Been Underestimated? : Provocative Findings From the Framingham Heart Study Circulation, February 15, 1996; 93(4): 638 - 640. [Full Text]
|
|